New Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really?

A new study has reported the effectiveness of raising glutathione levels in the blood through oral supplementation of liposomal glutathione. However, the team at Inid Research Labs that developed the ...

Microwave carrots, air-fry tomatoes: Researchers identify sustainable cooking methods for better nutrition

Researchers at the University of Seville's Food Color and Quality Laboratory have studied the effects of different cooking ...
Business Wire

Valbiotis Announces Positive Results in the Bioavailability and Mode of Action TOTUM•854 Clinical Study, Against High Blood Pressure

LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company, with a commercial ...
PharmTech

Relative Bioavailability Trial of Nanotechnology-Enhanced Enzalutamide is Underway

Nanoform has completed the First Subject First Visit in a trial evaluating the relative bioavailability of its nanotechnology-enhanced enzalutamide. Finnish medicine performance enhancing company, ...
Nature

Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet

To compare the impact of dietary important flavonoids, it is necessary to study them in the same food matrix and at similar realistic doses. The present study investigates the bioavailability and ...
PR Newswire

Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide

HELSINKI, Jan. 5, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV) in a trial ...
ascopubs.org

A phase I study to determine the comparative bioavailability of two different oral formulations of the PARP inhibitor, olaparib (AZD2281), in patients with advanced solid tumors.

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...